Introduction. CG McMahon 1 * and K Touma 1

Similar documents
Is there a role of radial rigidity in the evaluation of erectile dysfunction?

ERECTILE DYSFUNCTION DIAGNOSIS

D Udelson, A Nehra, DG Hatzichristou, K Azadzoi, RB Moreland, RJ Krane, I Saenz de Tejada and I Goldstein

Near infrared spectrophotometry for the diagnosis of vasculogenic erectile dysfunction

Erectile dysfunction. By Anas Hindawi Supervised by Dr Khalid AL Sayyid

Citation 泌尿器科紀要 (1988), 34(7):

H#{149}. Color Doppler Sonography in the Evaluation of Erectile Dysfunction: Patterns of Temporal Response to Papaverine

Spring balance evaluation of the ischiocavernosus muscle

Different hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders

Guidelines, Policies and Statements. Guidelines for Penile Colour Duplex Ultrasound Examination

High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction

GUIDELINES ON ERECTILE DYSFUNCTION

Erectile dysfunction following Nd-YAG visual laser-assisted prostatectomy (VLAP)

Onset and duration of action of sildena l citrate for the treatment of erectile dysfunction

MALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara

ANALYSIS OF NOCTURNAL PENILE TUMESCENCE WITH CONTINUOUS MONITORING OF PENILE RIGIDITY

Testosterone and PDE5 inhibitors in the aging male

Defined as the consistent inability to attain and maintain an erection adequate for sexual intercourse Usually qualified by being present for several

Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study

Introduction. D Sandhu 1, E Curless 2, J Dean 3, G Hackett 4, S Liu 5, D Savage 6, R Oakes 7 * and G Frentz 8

DOPPLER ULTRASOUND FOR ERECTILE DYSFUNCTION

GUIDELINES ON ERECTILE DYSFUNCTION

BJUI. Study Type Diagnostic (case series) Level of Evidence 4 OBJECTIVE CONCLUSIONS

MEDICAL POLICY SUBJECT: ERECTILE DYSFUNCTION. POLICY NUMBER: CATEGORY: Miscellaneous

Introduction. H Porst

Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction

Erectile dysfunction as a predictive factor for coronary artery disease

Clinical Case Reports: Open Access

INVESTIGATIONAL PLAN

Sexual function and dysfunction in men

Managing the Patient with Erectile Dysfunction: What Would You Do?

Sexual impotence. the forgotten complication

Penile duplex sonography in the diagnosis of

A NEW HARMLESS METHOD FOR THE DIAGNOSIS OF THE ERECTILE DYSFUNCTION: THE DIGITAL INFLECTION RIGIDOMETER

INVESTIGATIONAL PLAN

Imaging for Peripheral Vascular Disease

, David Stultz, MD. Erectile Dysfunction. David Stultz, MD September 10, 2001

The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction

ERECTILE DYSFUNCTION TREATMENTS

Erectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016

Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction

THE RELEVANCE OF TESTOSTERONE THERAPY IN MANAGING PATIENTS WITH ERECTILE DYSFUNCTION

aviptadil / phentolamine 25 micrograms / 2mg solution for injection (Invicorp ) SMC No 1284/17 Evolan Pharma AB

Ian Eardley Department of Urology, Leeds Teaching Hospital Trust

The anocavernosal erectile dysfunction syndrome II Anal ssure and erectile dysfunction

Review of intraurethral suppositories and iontophoresis therapy for erectile dysfunction

Sexual dysfunction in men with multiple sclerosis Ð A comprehensive pilot-study into etiology

Disclosure Slide. Dr Michael Gillman IMPOTENCE ERECTILE DIFFICULTIES. Do Men Really Care??? 15/10/2014 ASSESSMENT OF ERECTILE DYSFUNCTION

Colour Doppler and duplex ultrasound assessment of Peyronie's disease in impotent men

Value of flaccid penile ultrasound in screening for arteriogenic impotence: a preliminary prospective study

Prevalence of anxiety and depressive symptoms in men with erectile dysfunction

Managing Erectile Dysfunction

WITH ERECTILE DYSFUNCTION


INTRACAVERNOSAL INJECTION OF PHARMACOLOGICAL AGENTS IN THE DIAGNOSIS AND TREATMENT OF IMPOTENCE

Smooth muscle pathology and erectile dysfunction

A Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction

Carotid intima media thickness as an usefull tool in predicting cerebrovaskular events

A dose-response study of alprostadil sterile powder (S.Po.) (Caverject # ) for the treatment of erectile dysfunction in Korean and Indonesian men

Measure #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

Impotence and Blood Pressure in the Flaccid Penis:. Relationship to Nocturnal Penile Tumescence

Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

Miscellaneous. The Relationship between Lipid Profile and Erectile Dysfunction MOHAMMADREZA NIKOOBAKHT*, MAZIAR POURKASMAEE, HAMIDREZA NASSEH

ERECTILE DYSFUNCTION. Prof. Khan Abul Kalam Azad. Head, Department of Medicine, Dhaka Medical College President, Bangladesh Society of Medicine

CLINICAL RESEARCH Effects of alpha-2 blockade on sexual response: experimental studies with Delequamine (RS15385)

Carotid Ultrasound: Improving Ultrasound

GUNDERSEN/LUTHERAN ULTRASOUND DEPARTMENT POLICY AND PROCEDURE MANUAL

Clinical evaluation of Tentex forte and Himcolin cream in the treatment of functional erectile dysfunction

Investigation of erectile dysfunction

Central hemodynamics and prediction of cardiovascular events in patients with erectile dysfunction

IC351 (tadalafil, Cialis): update on clinical experience

The Accuracy of a Volume Plethysmography System as Assessed by Contrast Angiography

Male Pelvic Health following Pelvic Surgery

Erectile dysfunction (ED) is the inability to obtain or maintain an erection satisfactory

Conferences and Reviews New Developments in the Diagnosis and Treatment of Impotence

ERECTILE DYSFUNCTION. & Current Therapies. GP Conference, Rotorua 7-10 June 2012

/04/ /0 Reprinted from Vol. 172, , August 2004 THE JOURNAL OF UROLOGY

Male Sexual Dysfunction:

Double-blind, placebo-controlled safety and ef cacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction

Does kidney transplantation onto the external iliac artery affect the haemodynamic parameters of the cavernosal arteries?

Erectile dysfunction as an early sign of cardiovascular disease

EAU Guidelines on Erectile Dysfunction, Premature Ejaculation, Penile Curvature and Priapism

Guidelines on Erectile Dysfunction

(Department of Radiology, Beylikdüzü State Hospital, İstanbul, Turkey) Corresponding Author: Dr. Mete Özdikici

Disclosure Statement:

Erectile Dysfunction; It s Not Just About Sex

AHMED T. AHMED, M.D.*; GAMILA M. ALI, M.D.**; AHMED A. HWARY, M.D.** and LAILA K. ABD EL-KREAM, M.Sc.***

Immediate penile prosthesis insertion after failed T shunt and snake maneuver in patient with prolonged priapism

Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease

Sympathetic Vasomotor Response Of The Radial Artery In Patients With End Stage Renal Disease

Erectile Dysfunction: A Primer for Primary Care Providers

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients

6.2 Elements for a Public Summary

Categorical Course: Update of Doppler US 8 : 00 8 : 20

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

/03/ /0 Vol. 170, , July 2003 THE JOURNAL OF UROLOGY. Printed in U.S.A. Copyright 2003 by AMERICAN UROLOGICAL ASSOCIATION

Assessment of Erectile and Ejaculatory Function after Penile Prosthesis Implantation

Review Article Penile Rehabilitation Therapy with PDE-V Inhibitors Following Radical Prostatectomy: Proceed with Caution

Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men

Transcription:

Predictive value of patient history and correlation of nocturnal penile tumescence, colour duplex Doppler ultrasonography and dynamic cavernosometry and cavernosography in the evaluation of erectile dysfunction CG McMahon 1 * and K Touma 1 1 Australian Centre for Sexual Health, St. Luke's Hospital, Sydney, Australia International Journal of Impotence Research (1999) 11, 47±51 ß 1999 Stockton Press All rights reserved 0955-9930/99 $12.00 http://www.stockton-press.co.uk/ijir Aims: The results of history and physical examination, nocturnal penile tumescence testing (NPT), colour ow duplex Doppler ultrasonography and dynamic infusion cavernosometry and cavernosography (DICC) were retrospectively correlated in 207 patients with erectile dysfunction. Methods and materials: The predictive value of the patient's own subjective assessment of early morning and nocturnal erections, history of cigarette smoking, the presence of vascular risk factors was correlated to the outcome of investigations. The result of Rigiscan NPT was correlated to the peak systolic velocity (PSV) and the resistance index (RI) determined at colour ow duplex Doppler ultrasonography, and the maintenance ow rate (Q m ) determined at DICC. Results: Eighty- ve out of two hundred and seven patients (41%) had normal NPT comprising 48 out of 85 patients (56%) who described rigid early morning and nocturnal erections, 15 out of 85 patients (18%) who smoked cigarettes and 9 out of 85 patients (11%) with other positive vascular risk factors. 72 out of 85 patients (85%) had a normal PSV (>30 cm=s), 80 out of 85 patients (94%) had a normal RI (>0.85) and 82 out of 85 patients (96%) had a normal Q m ), (<10 ml=min). Vascular investigations in this group identi ed 71 out of 85 patients (84%) with no penile vascular disease, 11 out of 85 patients (13%) with arteriogenic impotence, 2 out of 85 patients (2%) with mixed vasculogenic impotence and 1 out of 85 patients (1%) with cavernosal venous leakage (CVL). One hundred and twenty-two out of two hundred and seven patients (59%) had an abnormal NPT comprising 18 out of 122 patients (15%) who continued to experience rigid early morning erections, 65 out of 122 patients (53%) who smoked cigarettes, 59 out of 112 patients (48%) with other positive vascular risk factors, 36 out of 112 patients (29%) had an abnormal PSV (<30 cm=s), 49 out of 122 patients (40%) had an abnormal RI (<0.85) and 55 out of 122 patients (45%) had an abnormal Q m (>10 ml=min). Vascular investigations in this group identi ed ve patients with no penile vascular disease, 51 out of 122 patients (41%) with arteriogenic impotence, 31 out of 122 patients (25%) with cavernosal venous leakage (CVL) and 35 out of 122 patients (29%) with mixed vasculogenic impotence. Conclusions: (1) a history of cigarette smoking and positive vascular risk factors are good predictors of organic impotence whereas the patient's subjective assessment of his own early morning erections is unreliable; (2) normal NPT correlates well with normal PSV, RI and Q m but does not exclude organic impotence; (3) abnormal NPT correlates well with abnormal PSV, RI and Q m. Keywords: impotence; erectile dysfunction; nocturnal penile tumescence; penile duplex ultrasonography; DICC Introduction The management of erectile dysfunction (ED) may require identi cation of the exact aetiology as psychogenic, vasculogenic, neurogenic, endocrinergic or mixed. Current opinion is that the patient *Correspondence: Dr CG McMahon, 175 Burns Bay Road, Lane Cove, Sydney, NSW 2066, Australia. Received 5 June 1998; revised 29 June 1998; accepted 15 July 1998 work-up is goal directed and includes a medical and sexual history, a physical examination and a discussion of available treatment options. Selected patients may require further evaluation with a variety of investigations including penile biothesiometry, nocturnal penile tumescence testing (NPT), colour duplex Doppler ultrasonography (CDU), dynamic infusion cavernosometry and cavernosography (DICC) and selective pudendal pharmacoangiography. Many investigations have reported that certain aspects of the sexual history, such as the absence of

48 morning erections, are suf cient to exclude psychogenic impotence. Others claimed that one speci c test is suf cient for differentiating between the varied aetiologies of ED. A retrospective study was designed to determine the predictive value of the patient's history as to the exact aetiology of his ED by correlating aspects of that history with the results of NPT, CDU and DICC, and to determine the correlation between the results of NPT, CDU and DICC. subjective assessment of morning and masturbatory erections, the presence of vascular risk factors, diabetes mellitus, lifestyle risk factors such as cigarette smoking and alcohol abuse were compared to the results of penile CDU and DICC in and between both groups. A risk factor pro le was established by correlation of these results in an attempt to identify the relative risk of ED for each risk factor. Results were statistically analysed using Student t-tests. Material and methods Results A total of 207 non-consecutive patients with a mean age of 48.6 y (range 19±61 y) with chronic ED where an aetiological diagnosis of ED was required underwent a standard full work-up comprising a medical and sexual history, a physical examination, fasting lipids and standard biochemistry, nocturnal penile tumescence testing (NPT), colour duplex Doppler ultrasonography (CDU) and dynamic infusion cavernosometry and cavernosography (DICC) between October 1994 and June 1996. Speci c attention was directed towards the presence of known vascular risk factors such as a history of hypertension, coronary artery disease, peripheral vascular disease and dyslipidaemia. Ambulatory NPT was performed (RigiScan (Dacomed Corp., Minneapolis, MN)) on three nights, regarding recordings with a base rigidity of 65%, a base expansion of 3.5 cm and a tip expansion of 2.5 cm as indicative of normal sleep erections. Penile CDU (Toshiba Sonolayer) was performed following intracavernous challenge and, if indicated, re-challenge, with Prostaglandin E1 (20 mcg) with serial measurement of peak systolic velocity (PSV), end diastolic velocity (EDV), resistance index (RI) and cavernosal artery diameter and assessment of cavernosal morphology until either a full erection or plateau haemodynamic parameters were achieved. DICC was performed following intracavernous challenge of Papaverine (60 mg) and Phentolamine (2 mg) with serial re-challenge until a linear relationship between intracavernous pressure and infusion ow rate was achieved indicating maximal smooth muscle relaxation, 1 and subsequent infusion with dilute non-ionic radiological contrast. Generally accepted normal values were used regarding a PSV less than 30 cm=s as indicative of arterial insuf ciency and Q m in excess of 10 ml=min, d ccp in excess of 2 mm Hg=s and RI less than 0.85 as indicative of cavernosal venous leakage (CVL). On the basis of the NPT results, patients were divided into one group with normal sleep erections and a second group with poor or absent sleep erections. The duration of ED, the patient's own The results of NPT were normal in 85 out of 207 men (41%) and abnormal in 122 out of 207 (59%). In men with normal NPT, the mean duration of ED was 3.1 1.1 months. Early morning erections and masturbatory erections were reported by 48 out of 85 men (56%) and 52 out of 85 men (61%) respectively in this group. In this group, 15 out of 85 men (18%) smoked cigarettes, 9 out of 85 men (11%) had positive vascular risk factors, 6 out of 85 men (7%) had diabetes mellitus and 12 out of 85 men (14%) admitted to alcohol abuse (Table 1). In patients with abnormal NPT, the mean duration of ED was 15.6 9.2 months. Early morning erections and masturbatory erections were reported by 18 out of 122 men (15%) and 9 out of 122 men (7%) respectively in this group. In this group, 65 out of 122 men (53%) smoked cigarettes, 59 out of 122 men (48%) had positive vascular risk factors, 25 out of 122 men (20%) had diabetes mellitus and 20 out of 122 men (16%) admitted to alcohol abuse (Table 1). Patients who either smoked cigarettes or suffered from diabetes mellitus were both 2.9 times more likely to have organic ED than nonsmokers or nondiabetics. The presence of positive vascular risk factors increased the likelihood of organic ED by a factor of 4.4. Alcohol abuse increased the risk of organic ED by a factor of only 1.1. In patients with normal NPT, 72 out of 85 men (85%) had a normal PSV, 80 out of 85 men (94%) Table 1 Incidence of certain aspects of the patient history in men with a normal NPT and men with an abnormal NPT Parameter Normal NPT n ˆ 85 (41%) Abnormal NPT n ˆ 122 (59%) Duration of ED 3.1 1.1 mo. 15.6 9.2 mo. Presence of EME 48 (56%) 18 (15%) Presence of ME 52 (61%) 9 (7%) Cigarette smoking 15 (18%) 65 (53%) Vascular risk factors 9 (11%) 59 (48%) Diabetes mellitus 6 (7%) 25 (20%) Alcohol abuse 12 (14%) 20 (16%) EME ˆ early morning erection and ME ˆ masturbatory erections.

Table 2 Results of NPT results, penile CDU and DICC history in men with a normal NPT and men with an abnormal NPT Parameter had a normal RI and 82 out of 85 men (96%) had a normal Q m. In patients with abnormal NPT, 36 out of 122 men (29%) had a normal PSV, 49 out of 122 men (40%) had a normal RI and 55 out of 122 men (45%) had a normal Q m (Table 2). On the basis of the results of CDU and DICC, patients were categorised as suffering from psychogenic impotence in 76 out of 207 men (37%), arteriogenic impotence in 62 out of 207 (30%), cavernosal venous leakage (CVL) in 32 out of 207 (15.5%) and mixed vasculogenic impotence in 37 out of 207 (18%). Of the 76 men categorised as suffering from psychogenic impotence, 71 out of 76 (93%) had a normal NPT and 5 out of 76 (7%) had an abnormal NPT. Of the 62 men categorised as suffering from arteriogenic impotence, 11 out of 62 (18%) had a normal NPT and 51 out of 62 (82%) had an abnormal NPT. Of the 32 men categorised as suffering from cavernosal venous leakage (CVL), 1 out of 32 (3%) had a normal NPT and 31 out of 32 (97%) had an abnormal NPT. Of the 37 men categorised as suffering from mixed vasculogenic impotence, 2 out of 37 (5%) had a normal NPT and 35 out of 37 (95%) had an abnormal NPT (Table 3). Discussion Normal NPT n ˆ 85 (41%) Abnormal NPT n ˆ 122 (59%) Normal PSV 72 (85%) 36 (29%) Normal RI 80 (94%) 49 (40%) Normal Q m 82 (96%) 55 (45%) Table 3 Results of NPT in patients with a diagnosis of psychogenic impotence, arteriogenic impotence, with cavernosal venous leakage and mixed vasculogenic impotence based on the results of penile CDU and DICC Aetiology n Normal NPT Abnormal NPT Psychogenic 76 71 5 Arteriogenic 62 11 51 Cavernosal venous leakage 32 1 31 Mixed vasculogenic 37 2 35 In this study, several clear differences are evident in patient symptomatology, medical history and lifestyle between men with a normal NPT and men with an abnormal NPT. Men with normal NPT presented earlier for treatment at 3.1 months as opposed to 15.6 months for men with abnormal NPT. This is consistent with the often abrupt onset of psychogenic ED and the insidious onset of vasculogenic ED. More than half of the men with abnormal NPT (53%) (65 out of 122) smoked cigarettes as opposed to only 15% (15 out of 85) of men with a normal NPT. In men with an abnormal NPT, 47% had other vascular risk factors, 20% had diabetes mellitus and 16% had reported and=or biochemical evidence of alcohol abuse as opposed to 11%, 7% and 14% respectively in men with normal NPT. The prevalence of cigarette smoking, other vascular risk factors and diabetes was signi cantly higher in men with an abnormal NPT (all P < 0.01) whereas the prevalence of alcohol abuse was not signi cantly different between the two groups. The risk factor pro le for men with organic ED in this study included lifestyle issues such as cigarette smoking and concurrent illness such as diabetes mellitus, hypertension, coronary artery disease, peripheral vascular disease and dyslipidaemia. Alcohol abuse increased the risk of organic ED by a factor of only 1.1 and, as such, is not regarded as a signi cant risk factor. As such, a history of cigarette smoking, positive vascular risk factors and diabetes in men with ED appears to be a good predictor of the presence of an organic aetiology. It is generally accepted that the most common cause of ED is penile vascular disease due to cavernosal artery atherosclerosis, cavernosal venous leakage or as a combination of both. Morley et al 2 and Wabrek et al 3 have both reported an increased incidence of coronary artery disease in men with ED secondary to cavernosal artery atherosclerosis. More recently, Greenstein et al 4 reported a statistically signi cant correlation between erectile function and the number of coronary vessels involved in a group of 40 men with coronary artery disease who underwent coronary angiography. As such, vasculogenic ED can be regarded as a predictor of the possibility of a patient subsequently developing symptomatic coronary artery disease. Accordingly the prompt and accurate diagnosis of the aetiology of ED assumes additional signi cance in men with cavernosal artery atherosclerosis, as it allows the patient to reduce his vascular risk factor pro le by adopting appropriate life style changes, thereby potentially reducing the risk of developing symptomatic coronary artery disease. As such, the reliability of the investigations used in the diagnosis of the aetiology of ED has added signi cance. The term `gold standard' has been applied to many of the investigation used in the evaluation of men with ED, implying high levels of diagnostic speci city and sensitivity and consequently a low incidence of false diagnosis. As a result, the evaluation of many men with ED is often streamlined to include one of these `gold standard' investigations, for example, NPT and CDU, in an attempt to make establishing an aetiological diagnosis minimally invasive and cost-effective. 49

50 Sleep laboratory NPT with polysomnography has been described as the `gold standard' investigation to distinguish psychogenic from organic ED. The role and accuracy of ambulatory continuous recordings of penile tumescence and rigidity with the Rigiscan has been validated and a nomogram of normal values reported by several authors. Colour Duplex ultrasonography has been reported in multiple studies as the `gold standard' investigation for the diagnosis of penile vascular disease. Benson and Vickers reported a close correlation between the results of penile CDU and pharmacoangiography in 20 patients. 5 Of the 40 cavernous arteries studied, 11 out of 11 men with a PSV < 25 and 13 out of 17 arteries with a PSV between 25 and 35 had arterial occlusive disease on pharmacoangiography whereas only 1 artery with a PSV greater than 35 cm=s had an abnormal angiogram. Similar results were reported by Brandsetter et al 6 who reported a high level of sensitivity and speci city of penile CDU for diagnosis of arterial occlusive disease with identical diagnosis in 34 out of 42 patients also studied with angiography. Davis et al 7 reported that a medical history and physical examination had a 95% sensitivity but only 50% speci city in diagnosing organic ED. Lehman et al 8 found that patient-reported sexual functioning revealed no characteristics predictive of the outcome of penile CDU. In contradiction to these ndings, Segraves et al 9 reported that patient reported presence or absence of early morning erections correctly assigned 100% of the men studied with organic ED and 86% of the men with psychogenic ED. Ackerman et al 10 reported similar results and concluded that patient reports of morning erections accurately predicted NPT results. In this study, only 56% (48 out of 85) men with normal NPT reported waking erections and only 61% (52 out of 85) described erections in response to fantasy and erotic material. Predictably, very few patients with abnormal NPT reported rigid waking erections 14% (18 out of 122) and erotic erections 7% (9 out of 122) in response to fantasy or erotic materials. Our experiences parallel the experience of Lehman's group in suggesting that patient's subjective reports of waking and masturbatory erections are poor predictors of the outcome of NPT in men with psychogenic ED. Furthermore, the presence of patient reported waking and masturbatory erections in 15% and 7% of men categorised as having organic ED, brings into further doubt the accuracy of penile blood ow investigations (penile CUD and DICC) upon which the diagnosis of organic ED is largely based. Kaneko and Bradley 11 reported that 27.3% of patients in their study group diagnosed with psychogenic impotence on the basis of their history including a psychosexual assessment and physical examination demonstrated abnormal nocturnal rigidity on NPT testing. In this study only 5 out of 76 men with a clinical diagnosis of psychogenic ED had abnormal NPT. Several authors have reported their experience and have compared the results of penile CDU, DICC and NPT, often with con icting conclusions. Shabsigh et al 12 reported that penile CDU correlated well with sleep laboratory NPT in 44 out of 50 patients studied. Of the remaining six patients, three had an abnormal penile CDU with a normal NPT study and three had an abnormal NPT study with a normal penile CDU. Sattar et al 13 reported their experience with a series of 50 patients studied with NPT, CDU and DICC where normal NPT results correlated well with normal PSV and normal DICC, but abnormal NPT had a low correlation with EDV and DICC and no correlation with abnormal PSV. They concluded that all three investigations should be performed to achieve a reasonably accurate diagnosis. Contrary to these studies, Allen et al 14 reported a poor correlation of penile CDU with sleep laboratory NPT in a prospective blinded study of 40 men. An abnormal penile duplex was found in 20 out of 40 men studied yet 9 of this group of 20 men had a normal NPT study. Of the remaining 20 men who had a normal duplex study, 11 had an abnormal NPT. They suggested that caution be exercised with abnormal duplexes if there is clinical evidence of psychogenic ED. Scott et al 15 in a study of 34 patients, made similar conclusions to Allen et al 14 and reported a good correlation between the results of penile CDU and DICC but no correlation between these vascular investigations and NPT. In this study, a PSV within the normal range was found in 84% (72 out of 85) of men with a normal NPT study. The remaining 16% (13 out of 85) men had an abnormal PSV suggesting penile arterial insuf ciency. A normal Q m and a RI > 0.85, suggesting a normal veno-occlusive mechanism, was found in 96% (82 out of 85) and 94% (80 out of 85) of men respectively with a normal NPT study, the remaining 1% (1 out of 85) and 6% (5 out of 85) men respectively having evidence of cavernosal venous leakage. Overall, evidence of either penile arterial disease, cavernosal venous leakage or both, was found in 16% (14 out of 85) men with a normal NPT comprising 11 men with arteriogenic ED, one man with CVL and two men with mixed vasculogenic ED. Evidence of penile vascular disease was found in 95% (117 out of 122) men with an abnormal NPT, the remaining ve men (4%) having normal penile CDU and DICC and being categorised as suffering from psychogenic ED. In this study, 11 out of 62 patients with arteriogenic ED, 1 out of 32 with cavernosal venous leakage and 2 out of 37 with mixed vasculogenic ED had a normal NPT. Overall, 14 out of 131 patients (11%) with vasculogenic ED had a normal NPT. An abnormal NPT was found in 5 out of 76 patients (7%) with psychogenic ED. Abnormal NPT appears to correlate reasonably well with abnormal penile

vascular investigations but a signi cant number of men with evidence of penile vascular disease, especially a low PSV, had a normal NPT study. Only 3 out of 69 men (4%) with CVL, either alone or as part of mixed vasculogenic ED, had a normal NPT, suggesting that CVL produces greater disruption of the erectile mechanism than does arteriogenic ED. Conclusions On the basis of these ndings, it seems reasonable to conclude that the patient's recollections of early morning and masturbatory erections are at best subjective, correlate poorly with the results of NPT testing and are unreliable in establishing an aetiological diagnosis. Furthermore, none of the investigations we currently use are entirely reliable and none can be regarded as the one `gold standard'. This study also reinforced the correlation between cigarette smoking, vascular risk factors and ED. If a de nite diagnosis is required before treatment is commenced and often it is not, that diagnosis must be based on a consensus derived from the patient's history, examination ndings and all investigations. In the current era of evidence-based medicine, the management of ED should ideally be based on an aetiological diagnosis which allows the treating physician to classify the severity of dysfunction, to assist the patient to select the most appropriate and acceptable therapy which addresses the pathology present and to advise patients with vasculogenic ED to reduce their vascular risk factor pro le by adopting appropriate life style changes, thereby potentially reducing the risk of developing symptomatic coronary artery disease. The availability of multiple medical therapies for ED and their potential for providing a `quick x' should not discourage the physician from establishing an aetiological diagnosis in most men. Accurate diagnosis allows us to identify the most appropriate and effective of these multiple treatments resulting in superior patient and partner satisfaction and better treatment outcomes. References 1 Hatzichristou DG et al. In vivo assessment of trabecular smooth muscle tone, its application in pharmaco-cavernosometry and analysis of intracavernous pressure determinants. J Urol 1995; 153: 1126±1135. 2 Morley JE, Korenman SG, Kaiser FE, Mooradian AD. Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men. Am J Med 1988; 84: 445±448. 3 Wabrek AJ, Burchell RC. Male sexual dysfunction associated with coronary heart disease. Arch Sex Behav 1980; 9: 69±75. 4 Greenstein A et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Imp Res 1997; 9: 123± 126. 5 Benson CB, Vickers MA. Sexual impotence caused by vascular disease: Diagnosis with duplex sonography. Am J Roentgenol 1993; 160: 71±73. 6 Brandsetter K et al. A comparison of colour duplex sonography with selective penile DSA in assessing erectile dysfunction. Rofo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren. 1993; 158: 405±409. 7 Davis-Joseph B, Tiefer L, Melman A. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology 1995; 45: 498±502. 8 Lehmann K, Eichlisberger R, Holtz D, Gasser TC. Sexually versus pharmacostimulated erections in assessment of patients with erectile dysfunction. In: Proceedings of the 92nd Annual Meeting of the American Urological Association. New Orleans, 1997. 9 Seagraves KA, Segraves RT, Schoengerg WH. Use of sexual history to differentiate organic from psychogenic impotence. Arch Sex Behav 1987; 16: 125±137. 10 Ackerman MD et al. Patient-reported sexual symptomatology in predicting functional and insuf cient erectile capacity. Urology 1991; 38: 437±442. 11 Kaneko S, Bradley WE. Evaluation of erectile dysfunction with continuous monitoring of penile rigidity. J Urol 1986; 136: 1026±1029. 12 Shabsigh R et al. Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J Urol 1990; 143: 924±927. 13 Sattar AA et al. Correlation of nocturnal penile tumescence monitoring duplex ultrasonography and infusion cavernosometry for the diagnosis of erectile dysfunction. J Urol 1996; 155: 1274±1276. 14 Allen RP, Engel RME, Smolev JK, Brendler CB. Comparison of Duplex ultrasonography and nocturnal penile tumescence in evaluation of impotence. J Urol 1994; 151: 1525±1529. 15 Scott DR et al. Comparison of penile vascular testing with ambulatory nocturnal penile tumescence monitoring for erectile dysfunction. In: Proceedings of the 91st Annual Meeting of the American Urological Association, Orlando, Florida, 1996. 51